FAQs
What was the market valuation of the US clinical reference-laboratories market in 2024?
The market valuation was $13.85 Billion in 2024.
What is the projected market valuation for the US clinical reference-laboratories market by 2035?
The projected valuation for 2035 is $27.56 Billion.
What is the expected CAGR for the US clinical reference-laboratories market during the forecast period 2025 - 2035?
The expected CAGR during the forecast period is 6.45%.
Which companies are considered key players in the US clinical reference-laboratories market?
Key players include LabCorp, Quest Diagnostics, Eurofins Scientific, Roche Diagnostics, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers, PerkinElmer, and Mayo Clinic Laboratories.
What were the valuations for the Stand Alone service provider segment in 2024?
The Stand Alone service provider segment was valued at $3.5 Billion in 2024.
What is the projected valuation for the Clinical Trials application segment by 2035?
The projected valuation for the Clinical Trials application segment by 2035 is $11.12 Billion.
How did the Hospital-Based service provider segment perform in 2024?
The Hospital-Based service provider segment was valued at $5.35 Billion in 2024.
What is the projected growth for the Laboratory medicine application segment from 2024 to 2035?
The Laboratory medicine application segment is projected to grow from $8.31 Billion in 2024 to $16.44 Billion by 2035.
What were the valuations for the Clinical Based service provider segment in 2024?
The Clinical Based service provider segment was valued at $5.0 Billion in 2024.
How does the market valuation in 2035 compare to that in 2024?
The market valuation in 2035 is expected to be approximately double that of 2024, increasing from $13.85 Billion to $27.56 Billion.